Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-week Prospective, Multicentre, Randomised, Double-blind, Placebo Controlled Study of Dysport® Injection for the Treatment of Upper Limb Spasticity in Early Stroke.

NCT00234546 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00234546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-week Prospective, Multicentre, Randomised, Double-blind, Placebo Controlled Study of Dysport® Injection for the Treatment of Upper Limb Spasticity in Early Stroke.
Lead sponsor
Ipsen
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2003
Completion date
October 31, 2007
Enrollment
162 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, muscle spasticity